| Pelvic Floor Disorder |
1 |
1 |
| Urinary Incontinence |
0 |
0.92 |
| Muscle |
0 |
0.69 |
| Incontinence |
0 |
0.63 |
| Breast Cancer |
0 |
0.49 |
| Urge Incontinence |
0 |
0.49 |
| Overactive Bladder |
0 |
0.23 |
| Social Determinants of Health |
0 |
0.23 |
| Sexual Dysfunction |
0 |
0.8 |
| Tissue |
0 |
0.13 |
| Brachial |
0 |
0.06 |
| Breast |
0 |
0.06 |
| Cancer |
0 |
0.06 |
| Chemotherapy |
0 |
0.06 |
| Child |
0 |
0.06 |
| Food and Drug Administration (FDA) |
0 |
0.06 |
| Grant |
0 |
0.06 |
| Health Care Quality, Access, and Evaluation |
0 |
0.06 |
| Impairment |
0 |
0.06 |
| Laser |
0 |
0.06 |
| Michigan |
0 |
0.06 |
| Rectum |
0 |
0.06 |
| Stress |
0 |
0.06 |
| Surgery |
0 |
0.06 |
| Tolerance |
0 |
0.06 |
| Vaginal Prolapse |
0 |
0.06 |